Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px
Document › Details

Expression Pathology Inc.. (12/20/05). "Press Release: Expression Pathology Signs Biomarker Discovery Deal with Digene Corporation". Gaithersburg, MD.

Organisations Organisation Expression Pathology Inc. (EPI)
  Today OncoPlex Diagnostics (OncoPlexDx)
  Group OncoPlex Diagnostics (OncoPlexDx)
  Organisation 2 Digene Corporation (Nasdaq: DIGE)
  Group Qiagen (Group)
Products Product Liquid Tissue MS Protein Prep Kit
  Product 2 proteomic marker (diagnostics)
Index term Index term Digene–Expression Pathology: biomarker discovery, 200512– collab service cancer protein biomarker discovery
Person Person Tunon, Peter (Expression Pathology 200501– VP Sales + Marketing)
     


Expression Pathology Inc. said today that it has entered into a research collaboration with Digene Corporation to identify cancer protein biomarkers in archived tissue using Expression Pathology’s proprietary Microproteomics Biomarker Discovery platform.

Under the terms of the agreement, Expression Pathology will employ its Liquid Tissue® MS Protein Prep reagents with LC MS/MS mass spectrometry to identify proteins in microdissected formalin-fixed tissue of known pathology and clinical history.

Digene Corporation (Nasdaq: DIGE, www.digene.com), based in Gaithersburg, MD, develops, manufactures and markets proprietary DNA and RNA testing systems for the screening, monitoring and diagnosis of human diseases -- with a focus on women's cancers and infectious diseases.

Expression Pathology Inc., based in Gaithersburg, MD, has developed innovative, proprietary techniques for protein analysis in formalin-fixed tissue. EPI’s products and services enable high throughput protein biomarker discovery and validation in archived tissue collections that are widely available, and provide the advantage of documented long-term clinical outcomes, such as disease progression, drug response and toxicity.

More information about EPI is available at www.expressionpathology.com.

For additional information, please contact:
Peter Tunon
Vice President Sales and Marketing
Expression Pathology Inc.
Main number 301 977 3654
Direct line 240 393 1927
Email p.tunon@expressionpathology.com

   
Record changed: 2016-03-19

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px

More documents for OncoPlex Diagnostics (OncoPlexDx)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px